Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cerebrospinal fluid lipidomic biomarker signatures of demyelination for multiple sclerosis and Guillain–Barré syndrome

27 Oct 2020

Abstract excerpt

Multiple sclerosis (MS) and Guillain-Barré syndrome (GBS) are demyelinating disorders affecting the central nervous system and peripheral nervous system (PNS), respectively. Cerebrospinal fluid (CSF) is one of the most valuable sources of diagnostic biomarkers in neurological diseases. In the present study high sensitivity shotgun mass spectrometry was used to characterise the CSF lipidome of patients with MS,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Long-Term Effects of COVID-19
Share to Multiple Sclerosis Research Studies
Share to Peripheral Neuropathies and Disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33110173
DOI: 10.1038/s41598-020-75502-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cerebrospinal fluid lipidomic biomarker signatures of demyelination for multiple sclerosis and Guillain–Barré syndromePMID 33110173Read ↗

Integrating Lipidomics and Transcriptomics Reveals the Crosstalk Between Oxidative Stress and Neuroinflammation in Central Nervous System DemyelinationSemantic proximity Read ↗

Integrative metabolomics reveals unique metabolic traits in Guillain-Barré Syndrome and its variantsSemantic proximity Read ↗

Utility of an untargeted metabolomics approach using a 2D GC-GC-MS platform to distinguish relapsing and progressive multiple sclerosisSemantic proximity Read ↗

Plasma lipidomics of monozygotic twins discordant for multiple sclerosisSemantic proximity Read ↗

Utility of an untargeted metabolomics approach using a 2D GC-GC‒MS platform to distinguish relapsing and progressive multiple sclerosisSemantic proximity Read ↗

Quantitative proteomics and multi-omics analysis identifies potential biomarkers and the underlying pathological molecular networks in Chinese patients with multiple sclerosisSemantic proximity Read ↗

Metabolomics reveals lipid and amino acid signatures of disease severity in multiple sclerosisSemantic proximity Read ↗

Multi-platform characterization of the human cerebrospinal fluid metabolome: a comprehensive and quantitative updateSemantic proximity Read ↗

Advances in mass spectrometry of lipids for the investigation of Niemann-pick type C disease.Semantic proximity Read ↗

Unveiling amyotrophic lateral sclerosis complexity: insights from proteomics, metabolomics, and microbiomicsSemantic proximity Read ↗

Molecular markers in the CSF proteome differentiate neuroinflammatory diseasesSemantic proximity Read ↗

Comprehensive phenotyping in multiple sclerosis: discovery based proteomics and the current understanding of putative biomarkers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.